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STUDY PROTOCOL Open Access
Preoperative exercise to improve fitness in
patients undergoing complex surgery for
cancer of the lung or oesophagus (PRE-
HIIT): protocol for a randomized controlled
trial
Gráinne Sheill1*, Emer Guinan2, Linda O’Neill1, Charles Normand3, Suzanne L. Doyle4, Sarah Moore5, John Newell6,
Grainne McDermott7, Ronan Ryan8, John V. Reynolds9 and Juliette Hussey1
Abstract
Background: Patients with cancer of the lung or oesophagus, undergoing curative treatment, usually require a
thoracotomy and a complex oncological resection. These surgeries carry a risk of major morbidity and mortality,
and risk assessment, preoperative optimisation, and enhanced recovery after surgery (ERAS) pathways are modern
approaches to optimise outcomes. Pre-operative fitness is an established predictor of postoperative outcome,
accordingly, targeting pre-operative fitness through exercise prehabilitation has logical appeal. Exercise prehabilitation is
challenging to implement however due to the short opportunity for intervention between diagnosis and surgery.
Therefore, individually prescribed, intensive exercise training protocols which convey clinically meaningful improvements
in cardiopulmonary fitness over a short period need to be investigated. This project will examine the influence of exercise
prehabilitation on physiological outcomes and postoperative recovery and, through evaluation of health economics, the
impact of the programme on hospital costs.
Methods: The PRE-HIIT Randomised Controlled Trial (RCT) will compare a 2-week high intensity interval training (HIIT)
programme to standard preoperative care in a cohort of thoracic and oesophageal patients who are > 2-weeks pre-
surgery. A total of 78 participants will be recruited (39 per study arm). The primary outcome is cardiorespiratory fitness.
Secondary outcomes include, measures of pulmonary and physical and quality of life. Outcomes will be measured at
baseline (T0), and post-intervention (T1). Post-operative morbidity will also be captured. The impact of PRE-HIIT on well-
being will be examined qualitatively with focus groups/interviews post-intervention (T1). Participant’s experience of
preparation for surgery on the PRE-HIIT trial will also be explored. The healthcare costs associated with the PRE-HITT
programme, in particular acute hospital costs, will also be examined.
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Discussion: The overall aim of this RCT is to examine the effect of tailored, individually prescribed high intensity interval
training aerobic exercise on pre-operative fitness and postoperative recovery for patients undergoing complex surgical
resections, and the impact on use of health services.
Trial registration: The study is registered with Clinical Trials.Gov (NCT03978325). Registered on 7th June 2019.
Keywords: Exercise, Preoperative care, Prehabilitation, Fitness
Background
Cancer prehabilitation is an essential component of the
multidisciplinary treatment model that optimises patient
outcomes at each step on the continuum of cancer care,
from diagnosis to survivorship [1, 2]. Prehabilitation
aims to reduce post-treatment morbidity and improve
pre-treatment health status to increase treatment op-
tions, typically surgical candidacy. With the evolution of
multimodal approaches to cancer treatment [3], there
are now multiple opportunities for prehabilitation in on-
cology care.
Attenuating postoperative risk is a key priority of pre-
operative assessment and enhanced recovery after sur-
gery (ERAS) protocols. In lung and oesophageal cancer,
complex surgical resection is the only curative interven-
tion, however these procedures are associated with sig-
nificant postoperative challenges and have the highest
mortality and major morbidity risk compared to other
oncologic surgeries. Postoperative pulmonary complica-
tions (PPCs), which are among the most serious postop-
erative morbidity, occur in 15–30% of patients post-
oesophagectomy and are the primary cause of postoper-
ative mortality, contributing to 45.5–55% of post-
oesophagectomy deaths [4]. Comparably, rates of PPCs
following thoracic surgery are 25% [5]. The impact of
postoperative complications, particularly PPCs on long-
term morbidity and quality of life (QOL) is well docu-
mented [6], and leads to significant hospital cost, driven
by increased use of critical care facilities, and protracted
hospital length of stay (LOS). The median cost of hospi-
talisation post oesophagectomy is $31,375 (€26,368),
however this increases by a further $20,777 (€17,461)
with serious postoperative complications [7]. Conse-
quently, interventions aimed at reducing postoperative
risk may have significant clinical and economic impact.
Cardiopulmonary fitness is an established indicator of
postoperative outcome and surgical candidacy. In intra-
abdominal surgery, low cardiopulmonary fitness, charac-
terised by an anaerobic threshold (AT) < 11 ml/kg/min
provides the most accurate indicator of postoperative
morbidity and hospital LOS [8]. Comparably, peak oxy-
gen consumption (VO2peak) < 10 ml/min/kg is predict-
ive of mortality and serious morbidity following major
thoracic operations [9]. While a relatively weak associ-
ation is reported between cardiopulmonary fitness and
oesophagectomy outcome specifically [1, 8], it follows
from the robust thoracic and intra-abdominal literature
that preoperative fitness is an important determinant of
oesophagectomy outcome. Furthermore, as oesophageal
cancer management moves towards multimodality [3],
the attrition impact of preoperative chemo(radio)therapy
leads to considerable physical deconditioning and loss of
preoperative fitness thus compromising post-operative
outcome [10]. In a multivariate analysis, a 1.0 ml/kg/min
increase in fitness reduced the odds of complications fol-
lowing colorectal resection by over 20% (OR 0.77 (95%
confidence interval (CI) 0.66–0.89) while an increase of
2.0 ml/kg/min was associated with a 40% reduction (OR
0.6 (95%CI 0.45–0.80) [11]. In intra-abdominal surgery,
prehabilitation involving inspiratory muscle training
(IMT), aerobic exercise and resistance training reduces
the incidence of postoperative complications by 41%
(OR 0.59 (95%CI 0.38–0.91), with the strongest impact
observed in relation to PPCs specifically [12].
While the evidence in intra-abdominal surgery is en-
couraging, little is known about exercise prehabilitation
for major thoracic operations on the lung or oesophagus.
Preliminary results from moderate-to-vigorous intensity
aerobic exercise programmes prior to thoracotomy for
lung cancer have reported improvements in pre-operative
cardiopulmonary fitness, and QOL, however trials are lim-
ited by single-armed designs and low participant numbers
[13]. Exercise prehabilitation for oesophagectomy has typ-
ically prescribed IMT, a form of exercise training which
strengthens the inspiratory muscles. While initial results
from IMT trials were encouraging, a randomised trial of
246 patients, reported no reduction in pneumonia rates or
PPCs following oesophagectomy with IMT [14], highlight-
ing the need to prescribe more intensive exercise training
to achieve a higher training stimulus for clinical impact.
High intensity interval training (HIIT) has significant
potential as an effective and feasible preoperative inter-
vention [15–17]. HIIT consists of alternating periods of
high-intensity aerobic exercise and low-intensity exercise
or rest, and stimulates superior improvements in
VO2peak compared to continuous moderate-intensity
aerobic training [15, 18]. The rationale for its use is to
increase training time spent at a high percentage of
VO2peak (> 80% VO2peak), thus producing a stronger
stimulus for cardiovascular and muscular adaptations.
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Consequently, HIIT provides the best opportunity to
create optimal improvements in fitness within the short
timeframe for oncologic resection within the clinical
pathway. In oncologic resection, preliminary evidence
indicates 12–15 sessions of HIIT significantly improves
cardiopulmonary fitness in low-fit older adults undergo-
ing lobectomy [16] and hepatic resection [17], however
further evaluation in larger cohorts and in those with
highest postoperative risk is required. Pilot research
from our group supports the feasibility and preliminary
efficacy of the proposed intervention.
The primary aim of this study is to improve pre-operative
fitness with high intensity interval training (HIIT). This
study will examine the physical and economic implications
of a targeted programme of exercise prehabilitation prior to
major oncologic resection for oesophageal and lung cancer.
The HIIT exercise programme will be considered in the
context of standard clinical pathways, involving pre-
operative oncological therapy and an enhanced approach to
postoperative recovery, and compared to standard care.
Methods
Study aims
The primary aim of this work is to examine the effect of a
preoperative high intensity interval training programme
on cardiorespiratory fitness in patients scheduled for oeso-
phagectomy and major lung resections.
Secondary aims are;
 To examine if individually prescribed preoperative
exercise training can reduce postoperative
complication rates following thoracic oncological
resections.
 To determine if individually prescribed preoperative
exercise training can impact post-operative physical
recovery following complex thoracic oncological
resections.
 To determine if individually prescribed preoperative
exercise training restores preoperative
cardiorespiratory fitness to pre-treatment levels in
patients treated with preoperative chemo(radio)therapy
and surgical resection.
 To examine if individually prescribed preoperative
exercise training can reduce postoperative
healthcare costs, in particular acute hospital costs.
 To qualitatively explore participant’s experience of
preparation for surgery on the PRE-HIIT trial.
Study design
PRE-HIIT will be implemented as a randomised con-
trolled trial with two arms: i) an intervention group of-
fered the 2-week HIIT programme in addition to
standard care, and ii) a control group receiving standard
survivorship care, which involves standard pre-operative
advice and a preoperative moderate intensity exercise
programme. Figure 1 depicts the flow of participants
through the study. The study will take place in the Well-
come Trust-Health Research Board (HRB) Clinical Re-
search Facility (CRF) at St James’s Hospital (SJH),
Dublin. Ethical approval has been sought from the Tal-
laght University Hospital (TUH)/ SJH Ethics Committee.
Any amendment to the protocol which may impact on
the conduct of the study will be submitted as an amend-
ment for approval to the ethics committees. The study
will be performed according to the Declaration of
Helsinki. The study is registered with Clinical Trials.Gov
(NCT03978325).
Study participants
Participant Selection Criteria:
Fig. 1 The Pre-HIIT Trial
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Inclusion criteria
 Patients who are scheduled for either
oesophagectomy (2-stage or 3-stage) or major lung
resection for the management of primary
oesophageal or lung cancer.
 Date of surgery ≥2 weeks from baseline (T0)
assessment
 Ability to provide written informed consent
 Absence of significant co-morbidities, including
metastatic disease, which may adversely impact
postoperative outcome
 Successful completion of a medically supervised
cardiopulmonary exercise test
 Patients with oesophageal cancer scheduled for
multimodal therapy including preoperative
chemo(radio)therapy and oesophagectomy will be
recruited and tested prior to treatment
commencement (Dx).
Exclusion criteria
The American Thoracic Society/American College of
Chest Physicians (ATS/ACCP) absolute contraindica-
tions for exercise testing will be applied [19].
In addition, patients undergoing video assisted lobec-
tomy (VATS) for early lung cancer will be excluded.
Recruitment and screening
The PRE-HIIT trial will recruit 78 patients. Participants
will be recruited from SJH, Dublin, Ireland. Participants
will be identified at pre-operative clinics and through in-
stitutional databases by their clinical team. Eligibility
screening will be completed by the research team at SJH.
All participants will require written medical clearance
from their treating consultant prior to enrolment. Poten-
tially eligible patients will be informed about the study
by a member of the research team (SJH) and will receive
a participant information leaflet. Following a reflection
period of 24–48 h, a researcher will telephone the pa-
tient to confirm their interest in participation. Patients
who are willing to participate will be invited to attend
the CRF at SJH to provide the research team with writ-
ten informed consent and for baseline testing.
Randomisation, allocation, concealment and blinding
Following baseline assessment (T0) and registration, par-
ticipants will be randomised in a 1:1 ratio to either the
PRE-HIIT programme or to the standard survivorship
care control group, using a computer-generated ran-
domisation list. Randomisation will be overseen by a co-
principle investigator, who will have no direct involve-
ment in implementing the trial.
Allocation order and treatment assignment will be
concealed from investigators using sealed envelopes
generated based on order of recruitment. Study assess-
ments will be performed by an assessor blinded to treat-
ment allocation. Due to the nature of the PRE-HIIT
programme, neither the programme implementation
staff nor patients can be blinded to the participants’ ran-
domisation assignment.
Intervention
Preoperative exercise intervention
The exercise intervention will take the form of a super-
vised programme, completed for at least 2 weeks, up to
5 days per week preoperatively. The feasibility of this
protocol has been established by our PHIIT trial, which
recruited patients scheduled for thoracotomy and colo-
rectal surgery at St James’s Hospital, with compliance
rates of 86% and adherence of 98%. Furthermore, the
study design is similar to the format prescribed by the
PREPARE trial [20], which specified a minimum study
duration (at least 2 weeks) but continued to prehabilitate
patients for longer in the lead up to surgery to optimise
the benefits gained [21]. The 2-week preoperative time-
line was found to be acceptable in the oesophagectomy
clinical pathway at our Centre.
The HIIT programme will be performed on an electro-
magnetically braked cycle ergometer in the exercise
physiology room at the CRF in St. James’s Hospital
under the supervision of a physiotherapist with experi-
ence in exercise prescription and exercise oncology. Ex-
ercise sessions will be individually supervised and
scheduled at a time of convenience for each participant.
Each exercise session will last 40 min and will include
warm-up, exercise training and cool-down components.
Lactate threshold, measured during the baseline CPET,
will be used to determine the exercise intensity.
The intervention will prescribe the same HIIT proto-
col used by the PHIIT trial, with established safety and
feasibility. The training protocol will prescribe 15 s inter-
vals of exercise and passive recovery. The highest resist-
ance reached during the baseline CPET (measured in
watts) will be recorded as the peak power output (PPO).
During training, participants will undergo a 5-min
warm-up at 50% PPO, followed by up to 30min of HIIT
with intervals of 15 s at 100% PPO with 15 s recovery pe-
riods at 0 watts. Vital signs including heart rate, blood
pressure, perceived exertion, and oxygen saturation
levels will be measured throughout. A 3-min cool down
will be performed upon session completion followed by
a passive recovery period of up to 7 min. Preliminary evi-
dence from both our PHIIT feasibility trial and the pub-
lished literature [16, 17], supports the hypothesis that
this exercise prescription will produce a clinically and
significantly meaningful increase in cardiopulmonary
fitness.
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Maintenance of nutritional adequacy
It is well established that cancer and its treatment can
have a significant negative impact on a patient’s nutri-
tional status. Participants randomised to the intervention
will receive an additional tailored dietetic assessment
with the exercise programme to ensure nutritional ad-
equacy is maintained throughout the duration of the
intervention. Sessions will focus on ensuring adequate
dietary energy (25-30kcals/kg/day) and protein intake
(1.25–1.5 g/kg/day). These reference levels are recom-
mended in the ESPEN guidelines for cancer patients [22].
Assessments will be carried out by a registered dietitian
with experience working with surgical oncology patients.
Standard preoperative care group
The standard care control group will not be invited to
participate in the HIIT exercise group. They will
however form an active control group, as standard pre-
operative care at St James’s Hospital includes standard
pre-operative exercise advice and prescription of a mod-
erate intensity exercise programme. Patients will also
complete preoperative assessments as described and re-
ceive pre-operative health education.
Measures
PRE-HIIT study outcomes are listed in Table 1. The main
assessment battery will be performed at; diagnosis
(oesophageal cancer patients scheduled for neoadjuvant
treatment) (DX), baseline (T0), and post-intervention (T1).
Quality of life will be further assessed at 3months post
intervention. Key timepoints for assessing outcomes of ex-
ercise prehabilitation intervention are outlined in Fig. 2. At
baseline information regarding socio-demographics will be
collected from patient interview and data pertaining to
Table 1 Pre-HIIT Outcomes
Outcome Instrument Diagnosis Baseline Post-intervention Post-
OperativelyDx T0 T1
Primary outcome
Cardiorespiratory fitness Cardiopulmonary Exercise Test (CPET) X X X
Secondary outcomes
Pulmonary and Physical Performance
Functional performance Short Physical Performance Battery (SPPB) X X X
Muscle Strength Leg Press 1-RM X X X
Physical activity International Physical Activity Questionnaire X X X
Pulmonary Function CPET X X X
Maximum Inspiratory Pressure PowerBreathe K-series X X X
Nutritional Status Dietary interview X X X
Quality of Life EORTC-QLQ-C30 X X X X
Cancer specific quality of Life EORTC-QLQ-OG25 (oesophago-gastric cancer) X X X X
EORTC-QLQ-LC 13 (lung cancer) X X X X
Qualitative approach Semi –structured interviews (focus groups or 1:1) X
Cost analyses EQ5D X
Service Use Inventory X
Post-operative morbidity
Post-operative outcomes Self-reported Functional Recovery X
Post-Operative Morbidity Score X
Clavien Dindo Score X
Comprehensive Complications Index X
Other
Adherence Record in case report form/ exercise diary X
Sociodemographic details Participant self-report X
Body composition Anthropometry X X
Cancer/Surgery history Medical records X
Adverse events Reports of patients/ research personnel X
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medical history, cancer diagnosis and treatments will be
obtained from patient’s medical records.
Primary outcome
Cardiopulmonary fitness
Cardiopulmonary fitness will be determined, by a max-
imal cardiopulmonary exercise test (CPET), the gold
standard measure of fitness [23]. Cardiopulmonary exer-
cise tests will be performed in the CRF at St James’s
Hospital under medical supervision at Dx (oesophageal
cancers only), T0 and T1. The CRF at St James’s is
equipped with an electromagnetically braked cycle erg-
ometer (COSMED, E200 P/K), COSMED K4b2 ambula-
tory metabolic system, integrated exercise ECG and
integrated blood pressure monitoring. The CPET will be
performed using a ramp cycle ergometer protocol. Fol-
lowing a standardised resting and warm-up period, test-
ing will commence with 3 minutes of free-wheel
pedalling after which resistance will increase by standar-
dised increments. The ramp gradient will be set to 10–
25W/min based on the equation below by Wasserman
et al. [24].
i. VO2unloaded in ml/min = 150 + (6 x weight kg)
ii. Peak VO2in ml/min = (height cm – age years) × 20
(sedentary men) × 14 for sedentary women
iii. Work rate increment minute/watts = (peak VO2ml/
min – VO2unloaded ml/min)/100)
Breath-by-breath gas analysis, heart rate, heart rhythm
(12-lead ECG), non-invasive blood pressure, oxygen sat-
uration, rate of perceived exertion and blood lactate will
be measured before, during and after testing. The test
will be terminated by a cool-down performed at a resist-
ance of 30 watts for 3 minutes and during which partici-
pants will be monitored for signs of distress (pallor,
chest pain, dyspnoea). VO2peak will be calculated as an
average over the last 30 seconds of exercise. AT will be
described as lactate threshold (LT) and ventilatory
threshold (VT). Lactate Threshold (LT) will be measured
via ‘a pin-prick’ blood sample, analysed using the ‘Stat
Strip Xpress LAC’ portable lactate monitor. Samples will
be collected and recorded every minute during the exer-
cise test. Post completion of the test, the results will be
inputted on a graph against time/work rate. The LT is
the point in which VO2 increases non-linearly, this will
be calculated via visual inspection, a valid method of de-
termining LT. VT will be determined through the modi-
fied v-slope method, which determines the point of the
change in slope of the relationship of VO2above which
VCO2 increases faster than VO2 without hyperinflation
[19]. Other components of fitness that will be obtained
from breath-by-breath analysis include: VE/VCO2, VE/
VO2, minute ventilation.
Secondary outcomes
Secondary outcome 1: postoperative morbidity
Postoperative morbidity will be measured using a suite
of validated instruments; the Clavien-Dindo Scale, the
postoperative morbidity index (POMS) and the Compre-
hensive Complications Index (CCI). These widely used
objective measures of postoperative complications, over-
come the known issues with standardising the definition
of postoperative complications [4]. In addition, hospital
and critical care LOS and postoperative mortality will be
recorded. All outcomes will be recorded on hospital dis-
charge and on POD30 with the exception of the POMS
which will additionally be recorded on POD3, POD5
and POD7 (Table 1).
Clavien-Dindo scale The Clavien-Dindo classification
score measures the most severe complication that occurs
in the postoperative period. The ordinal scale is divided
into seven grades (Grade I-V, two sub-groups each for
Fig. 2 Key timepoints for assessing outcomes of exercise prehabilitation intervention
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Grade III and IV), ranging from Grade I, which con-
siders any deviation from normal, to Grade V, which de-
scribes death of the patient. The tool is widely used due
to its simplicity and reproducibility, its correlation with
LOS, and the degrees of severity of complications also
correlate with the perceptions of severity of medical staff
and patients [25].
The post-operative morbidity score (POMS) The
POMS is a nine-domain tool that prospectively describes
and records in-hospital postoperative complications fol-
lowing major surgery [26]. The POMS, which is per-
formed on specific postoperative days, typically POD3,
POD5 and/or POD7, provides defined criteria for com-
plications in nine categories classified by organ system
including pulmonary, infectious, renal, gastrointestinal,
cardiovascular, neurological, haematological, wound and
pain.
The comprehensive classification index (CCI) The
CCI provides a summary of overall morbidity including the
type, number and severity of each complication experienced
during the postoperative period [25]. When compared to
the Clavien-Dindo Classification the CCI demonstrates a su-
perior ability to discriminate between patients with a differ-
ent number and severity of complications.
Secondary outcome 2: pulmonary and physical
performance
The training stimulus associated with HIIT may lead to
important improvements in secondary measures of phys-
ical performance including pulmonary function, ventila-
tory and peripheral muscle strength and functional
capacity [27], which may in turn positively impact post-
operative outcome. The following measures will be per-
formed at Dx, T0 and T1. Self-reported functional
recovery will be evaluated on POD30.
Pulmonary function Pulmonary function will be mea-
sured as the first step of the CPET and analysed as a sec-
ondary outcome. The COSMED K4b2 ambulatory
metabolic system will be used to determine forced vital
capacity (FVC), forced expiratory volume at 1 s (FEV1)
and the ratio of FEV1/FVC in accordance with the
American Thoracic Society Guidelines.
Maximal inspiratory pressure Maximal inspiratory
pressure (PImax) provides a non-invasive, simple meas-
ure of inspiratory muscle strength, particularly the dia-
phragm. PImax will measured using a PowerBreathe K-
series portable respiratory pressure metre. Patients will
be measured at residual volume during a forceful in-
spiratory manoeuvre while resting in a seated position.
All measures will be performed in triplicate with the best
measure taken for data entry.
Peripheral muscle strength Preliminary analysis of the
PHIIT trial participants has demonstrated a post-
intervention increase in peak power output, suggesting
some improvement in lower limb strength with the cycle
ergometer HIIT protocol. In the proposed study, quadri-
ceps muscle strength will be measured by 1 repetition
maximum (1RM) using a horizontal leg extension. The
1RM is defined as the highest load that can be lifted
through full range of movement at one time. Participants
will complete 1RM testing following adequate aerobic
warm up followed by a warm up of 6 repetitions at 60%
1RM with 2 min rest and then 3 repetitions at 80% 1RM
with 2 min rest. A maximum of 5 trials to determine
1RM will be completed with a rest period of 2 minutes
between each trial.
Functional performance This will be measured using
the Short Physical Performance Battery (SPPB). This
measure combines the results of gait speed, chair stand
and balance tests. A score lower than 10 indicates one
or more mobility limitations.
Self-reported physical activity Physical activity will be
measured subjectively using the self-administered Inter-
national Physical Activity Questionnaire (IPAQ). The
IPAQ long form comprises four activity domains (work,
leisure, transportation and household) which evaluates
activity in metabolic equivalent (MET)-hours per week
over the previous 7 days. The questionnaire also quanti-
fies average weekend and weekday sitting time. Data col-
lected on POD30 will be collected via a telephone call
with the participant.
Self-reported functional recovery Patient perceived
physical recovery at POD30 will be self-assessed using
standardised classifications. Participants will rate their
recovery as 0, 25, 50, 75% or 100% according to standar-
dised descriptors [28]. Data collected on POD30 will be
collected via a telephone call with the participant.
Secondary outcome 3: quality of life
The EORTC QOL questionnaire is an integrated system
for assessing the health related QOL of cancer patients
participating in international clinical trials. The core
questionnaire, the QLQ-C30 has been used in a wide
range of cancer clinical trials [29]. It is supplemented by
disease specific modules. Categories include functional
scales, global health status and QOL scale, in addition to
several single-item symptom measures. Disease specific
modules such as the oesophageal EORTC QLQ-OES18
and QLQ-OES25 and the lung EORTC QLQ-LC 13 can
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be used in conjunction with the main questionnaire to
monitor disease specific symptoms. In the current study,
QOL will be measured using EORTC QLQ-C30 and
relevant subsets at Dx, T0, T1 and on POD30.
QOL will be further measured using the EuroQol (EQ)
EQ-5D5L to analyse cost effectiveness of the interven-
tion. The EQ-5D5L comprises five dimensions: mobility,
self-care, usual activities, pain/discomfort and anxiety/
depression with each dimension rating activities as hav-
ing no problems, having slight problems, having moder-
ate problems, having severe problems and being unable
to do/having extreme problems. The EQ-5D5L will be
measured at routine post-operative clinic visits at 6
weeks and 3months postoperatively.
Changes in the QOL scores (both from EORTC QLQ
and EQ5D5L) will be analysed to identify any difference
in the profile of health related QOL in the two arms of
the study. If costs of hospital care are lower in the inter-
vention group, and if QOL scores are better post-
intervention, then the intervention will dominate (ie,
lower costs of hospital care, including the cost of the ex-
ercise programme, and better QOL of patients) and no
cost-effectiveness ratios can be calculated. Otherwise it
will be possible to estimate the additional cost of any
measured improvement in QOL post-intervention. Simi-
larly, if costs of care are lower in the intervention group
but QOL is also lower, it will be possible to estimate
cost-effectiveness ratios for this change.
Qualitative approach
At the pre-surgery assessment (T1) a sub-cohort of the
study’s participants will take part in a semi-structured
interview to feedback on how the PRE-HIIT study has
impacted on their preparation for surgery. Interviews
will be held with approximately 20 participants or until
data saturation is reached.
Adherence
Adherence to the exercise component of PRE-HIIT will
be measured with traditional adherence variables i.e. at-
tendance at supervised sessions and completion of
home-based sessions and monitoring of compliance to
the prescribed exercise protocol. Compliance to the aer-
obic component will be documented by the achieved
heart rates on the Polar Heart Rate Monitors, and the
duration of aerobic exercise, and for resistance training,
the weight, number of sets, and repetitions will be re-
corded. During the supervised sessions compliance will
be monitored by the supervising physiotherapist, whilst
during homebased sessions participants will record their
compliance in a home exercise diary. PRE-HIIT will im-
plement a series of drug trial adapted adherence out-
comes as described by Nilsen et al. [30]. These
additional exercise adherence variables will include;
permanent treatment discontinuation, treatment inter-
ruption, dose modification, early session termination,
and pre-treatment intensity modification. Adherence
variables are described fully in Table 1.
Hospital resources
The costing of hospital stays, and interventions will be
carried out based on activity data from hospital records,
with unit costs taken from the standard estimated costs
from the Healthcare Pricing Office. Programme imple-
mentation costs will be analysed in consideration of clin-
ician salaries, overheads and equipment costs. Formal
care costs will be extracted from medical charts and
from the institutional database in consideration of pre-
operative characteristics, surgery type and postoperative
recovery including complications. Since the participants
in the study are randomised to each arm, the compari-
son of costs of hospital stays will be reported as differ-
ences and the normal tests of significance. It is also
important to assess if the intervention has longer term
effects beyond hospital discharge. The destination at dis-
charge, use of community health services from the time
of discharge to the follow up outpatient appointment
and EQ5D5L scores at the time of the follow up ap-
pointment will be collected for each participant. This
will allow the measurement of any effects of the inter-
vention on the feasibility of the patient going home dir-
ectly from hospital, and any difference in the need for
community health services. The EQ5D5L scores at out-
patient follow up will allow an assessment if any short-
term difference persists and will assist in modelling the
likely medium-term effect of the intervention on costs
and QOL.
Safety
Prior to baseline testing, all participants will require
written medical approval confirming their suitability for
participation. Patients will only be formally enrolled on
the study after successfully completing a CPET with
ECG monitoring. All CPET will be medically supervised
and will take place in the CRF which is located within
SJH and is covered by the hospital’s emergency response
team. All adverse events will be recorded, and serious
adverse events will be reported to the research ethics
committees.
Sample size calculation
The primary response is the change in VO2peak from
baseline (T0) to post-intervention (T1). On the basis of
estimates calculated from our pilot study, a sample of
size 64 (32 in each arm) is needed in order to detect a
mean difference in VO2peak of 1 ml/kg/min between the
control and intervention groups (assuming a standard
deviation of change in VO2peak of 1.4 ml/kg/min for
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each arm) with 80% power at the 5% significance level
based on a two-sample t-test. Based on the results from
the PHIIT trial and others [16, 17], an improvement of
1 ml/kg/min in VO2peak is feasible with the exercise
intervention prescribed. It is anticipated that the active
control group will not experience a change in fitness
during this 2 week time period [16]. Moderate intensity
exercise interventions have not been shown to signifi-
cantly change preoperative aerobic capacity and func-
tional capacity of patients due to undergo elective
surgery [31].
Statistical analysis
Quantitative data analysis will be performed using R IBM
SPSS software, employing statistical best practice. A com-
parison of patient characteristics at baseline will be carried
out for each arm. Summary statistics for continuous vari-
ables (means and standard deviations or median and
ranges as appropriate) and categorical variables (counts
and proportions) will be presented. Graphical summaries
(boxplots, case profile plots, labelled scattered plots) will
be used to compare the distribution s of each response
variable and for patient characteristics between the arms.
A linear mixed model will be used to model the longitu-
dinal change in the primary response between the groups,
allowing for missing data (under the assumption that data
are missing at random) and allowing for within subject
correlations in the repeated measures across time. The
model will adjust for the baseline response variable and
other covariates as necessary.
A qualitative approach will be taken to gather partici-
pants’ feedback on how the PRE-HIIT study has im-
pacted on their preparation for surgery. Data collection
will take a semi-structured approach individual inter-
views following the intervention. The discussion guide
for the interviews will explore topics such as: the impact
of the intervention on health, well-being, and activities
of daily living, facilitators and barriers to preoperative
exercise, and recommendations for future implementa-
tion of the programme. Interviews will be digitally
audio-recorded and transcribed verbatim for data ana-
lysis. A qualitative descriptive approach [32] will be
taken to the analysis, with the aim of providing a sub-
stantial description of what the participants said, without
drawing deep implications from the data. Braun and
Clarke’s 6 stage approach to thematic analysis will be
used to analyse all data collected [33]. A team of re-
searchers will analyse all transcripts following an agreed
process using nVivo 12 (QSR International, Australia).
Data monitoring
Data monitoring will be provided by the trial steering
committee, including overall project supervision, pro-
gress monitoring, advice on scientific credibility and
ensuring the integrity and appropriate running of the
project. The research team will make quarterly reports
to the trial steering committee.
Dissemination
Findings of PRE-HIIT will be disseminated via peer-
reviewed publications and conference presentations. Ag-
gregate study results will be presented to participants
and their families at an education symposium upon
study completion. Anonymised data will be made avail-
able on an open access repository.
Public and patient involvement (PPI)
PRE-HIIT will involve a number of PPI initiatives. We
will seek feedback on participant documentation, par-
ticularly the participant information leaflet and consent
form, to ensure readability and clarity. In addition, a pa-
tient representative will be invited to speak at the educa-
tion symposium in the final year of the project.
Study status
PRE-HIIT will begin in recruitment in 2020.
Discussion
The PRE-HIIT RCT will examine the influence of pre-
operative high intensity interval training programme on
physiological outcomes and postoperative recovery and,
through evaluation of health economics, the impact of
the programme on hospital costs.
There is a need for clinically feasible interventions that
attenuate the impact of multiple therapeutic interven-
tions, most particularly major oncological operations,
and accelerate patient recovery. Prehabilitation is likely
to have its greatest impact in cancer populations who
experience the greatest treatment morbidity, such as
oesophageal and lung cancer. There is growing interest
in the value of exercise prehabilitation to increase pre-
operative fitness above critical values in oncologic resec-
tions [15]. HIIT exercise training stimulates great
improvements in cardiopulmonary fitness over short pe-
riods compared to continuous aerobic training and
therefore may be ideally suited to exercise prehabilita-
tion. This mode of exercise prehabilitation may attenu-
ate postoperative risk and improve postoperative
recovery, thus improving patient quality of life and hav-
ing considerable economic benefits for the healthcare
system. Given the high unit cost of hospital days and
procedures, the direct effects of the intervention on hos-
pital costs and any evidence of differences in QOL which
will be explored by the PRE-HIIT trial are of consider-
able interest. The results of this study will inform
current perioperative practice and will provide direction
for future research.
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